A nanomedicine approach enables co-delivery of cyclosporin A and gefitinib to potentiate the therapeutic efficacy in drug-resistant lung cancerWeidong Han, Hangxiang Wang|Signal Transduction and Targeted Therapy|2018Cited by 98